VEROVACCiNES
Latest round
- Series D
Last raised
- Mar 2025
Total raised
- $1.7M
Investors
- 3
About VEROVACCiNES
VEROVACCiNES GmbH, founded in 2017 in Halle, Germany, develops animal vaccines through a proprietary subunit vaccine platform.6 million.VEROVACCiNES GmbH specializes in the development of animal vaccines through an integrated subunit vaccine platform. The company's core offerings are novel vaccines that utilize recombinant strains of the yeast Kluyveromyces lactis, engineered to stably express antigens that elicit immune responses in target animals. This technology allows for the rapid creation, optimization, and registration of vaccines, providing a streamlined pathway from design to commercialization.VEROVACCiNES GmbH generates revenue through direct sales of its vaccine products to veterinary clinics and animal health distributors, establishing partnerships for broader market reach. The transaction structure is primarily B2B, with veterinary practices ordering vaccines in bulk for their clientele. These sales may involve long-term contracts with agricultural stakeholders requiring consistent access to animal vaccines. The company is focused on developing new vaccine products to enhance its offerings and aims to penetrate new geographic markets.
Who invested in VEROVACCiNES
3 investors across 2 rounds
See all investors in VEROVACCiNES
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about VEROVACCiNES
Who invested in VEROVACCiNES?
VEROVACCiNES has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has VEROVACCiNES raised?
VEROVACCiNES has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did VEROVACCiNES last raise money?
VEROVACCiNES's most recent round on record is a Series D, in Mar 2025.
What does VEROVACCiNES do?
VEROVACCiNES GmbH, founded in 2017 in Halle, Germany, develops animal vaccines through a proprietary subunit vaccine platform.
Where is VEROVACCiNES headquartered?
VEROVACCiNES is headquartered in Halle, Germany.
Which VCs invest in companies like VEROVACCiNES?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at VEROVACCiNES's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like VEROVACCiNES? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.